SOMATOSTATIN(5) RECEPTOR-MEDIATED [S-35] GUANOSINE-5'-O-(3-THIO)TRIPHOSPHATE BINDING - AGONIST POTENCIES AND THE INFLUENCE OF SODIUM-CHLORIDE ON INTRINSIC ACTIVITY
Aj. Williams et al., SOMATOSTATIN(5) RECEPTOR-MEDIATED [S-35] GUANOSINE-5'-O-(3-THIO)TRIPHOSPHATE BINDING - AGONIST POTENCIES AND THE INFLUENCE OF SODIUM-CHLORIDE ON INTRINSIC ACTIVITY, Molecular pharmacology, 51(6), 1997, pp. 1060-1069
We studied the activation of the human somatostatin, receptor recombin
antly expressed in CHO-K1 cells by using some newly available agonists
and antagonists. Somatostatin-28 bound to this receptor with a higher
affinity than somatostatin-14 and was more potent in increasing [S-35
]guanosine-5'-O-(3-thio)triphosphate (S-35]GTP gamma S) binding. Somat
ostatin-14-induced [S-35]GTP gamma S binding to membranes from this ce
ll line was decreased in a concentration-related manner by increasing
concentrations of GDP and sodium chloride. At 50 mM (low) sodium, agon
ist EC50 values for stimulating [S-35]GTP gamma S binding were lower t
han those at 150 mM (high) sodium and were closer to their respective
affinity estimates (dissociation equilibrium constants) for binding to
the receptor in the absence of sodium. Both agonist binding to the hi
gh affinity state of the receptor and agonist-induced [S-35]GTP gamma
S binding were abolished by pertussis toxin pretreatment. The putative
somatostatin(5) receptor-selective ligand L-362,855, unlike somatosta
tin-14 and somatostatin-28, showed differential intrinsic activity for
stimulation of [S-35]GTP gamma S binding, behaving as a partial agoni
st in high sodium and a full agonist in low sodium. In contrast, BIM-2
3056 did not behave as an agonist under any conditions studied but was
able to antagonize somatostatin-14-induced [S-35]GTP gamma S binding.
We conclude that measurement of [S-35]GTP gamma S binding mediated by
somatostatin receptor activation in the presence of different concent
rations of sodium chloride provides a useful functional assay for asse
ssing the relative agonist efficacies of novel ligands identified from
radioligand binding studies.